Suppr超能文献

吡啶并(2,3 - d)嘧啶类抗菌剂。3. 8 - 烷基和8 - 乙烯基 - 5,8 - 二氢 - 5 - 氧代 - 2 - (1 - 哌嗪基)吡啶并(2,3 - d)嘧啶 - 6 - 羧酸及其衍生物。

Pyrido(2,3-d)pyrimidine antibacterial agents. 3. 8-Alkyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids and their derivatives.

作者信息

Matsumoto J, Minami S

出版信息

J Med Chem. 1975 Jan;18(1):74-9. doi: 10.1021/jm00235a017.

Abstract

The preparation and antibacterial activity of a series of the title compounds (21-73) are described. These compounds were prepared from the 2-methylthio derivatives 2 and 3 via the 2-methylthio-8-substituted compounds 4-20; compounds 4-20 easily underwent displacement reactions with a variety of piperazines to afford 2-(4-substituted or unsubstituted 1-piperazinyl) derivatives 21-56, of which 21, 22, 27 and 51 with unsubstituted piperazinyl group at position 2 are converted subsequently into 57-73 by alkylation, acylation, sulfonylation, or addition of isocyanates to the piperazine nitrogen. The hexahydro-1H-1,4-diazepinyl analog 74 was also prepared. The most active members in this series of compounds were found to be 8-ethyl- and 8-vinyl-5,8-dihydro-5-oxo-2-(1-piperazinyl)pyrido(2,3-d)pyrimidine-6-carboxylic acids (22 and 51), both of which are more active in vitro and in vivo against gram-negative bacteria, including Pseudomonas aeruginosa, than piromidic acid (1). Structure-activity relationships are discussed.

摘要

本文描述了一系列标题化合物(21 - 73)的制备及其抗菌活性。这些化合物是由2 - 甲硫基衍生物2和3经2 - 甲硫基 - 8 - 取代化合物4 - 20制备而成;化合物4 - 20能与多种哌嗪容易地发生取代反应,得到2 -(4 - 取代或未取代的1 - 哌嗪基)衍生物21 - 56,其中2位带有未取代哌嗪基的21、22、27和51随后通过烷基化、酰化、磺酰化或向哌嗪氮上加成异氰酸酯转化为57 - 73。还制备了六氢 - 1H - 1,4 - 二氮杂卓基类似物74。发现该系列化合物中活性最强的成员是8 - 乙基 - 和8 - 乙烯基 - 5,8 - 二氢 - 5 - 氧代 - 2 -(1 - 哌嗪基)吡啶并[2,3 - d]嘧啶 - 6 - 羧酸(22和51),这两种化合物在体外和体内对包括铜绿假单胞菌在内的革兰氏阴性菌的活性均高于吡咯米酸(1)。文中讨论了构效关系。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验